Arnulf Stenzl
Researcher Next ID · RN-032114
Researcher · Medicine
Tübingen, Germany
- Works count
- 1,625
- Citation count
- 37,294
- H-index
- 87
- i10-index
- 578
Research interests
Publications
Current best practice for bladder cancer: a narrative review of diagnostics and treatments
The Lancet · 2022 · https://doi.org/10.1016/s0140-6736(22)01188-6
Improved Survival With Enzalutamide in Patients With Metastatic Hormone-Sensitive Prostate Cancer
Journal of Clinical Oncology · 2022 · https://doi.org/10.1200/jco.22.00193
Talazoparib monotherapy in metastatic castration-resistant prostate cancer with DNA repair alterations (TALAPRO-1): an open-label, phase 2 trial
The Lancet Oncology · 2021 · 10.1016/s1470-2045(21)00376-4
Prostate-specific Antigen Testing as Part of a Risk-Adapted Early Detection Strategy for Prostate Cancer: European Association of Urology Position and Recommendations for 2021
European Urology · 2021 · https://doi.org/10.1016/j.eururo.2021.07.024
European Association of Urology Guidelines Office Rapid Reaction Group: An Organisation-wide Collaborative Effort to Adapt the European Association of Urology Guidelines Recommendations to the Coronavirus Disease 2019 Era
European Urology · 2020 · https://doi.org/10.1016/j.eururo.2020.04.056
ARCHES: A Randomized, Phase III Study of Androgen Deprivation Therapy With Enzalutamide or Placebo in Men With Metastatic Hormone-Sensitive Prostate Cancer
Journal of Clinical Oncology · 2019 · https://doi.org/10.1200/jco.19.00799
Extended Versus Limited Lymph Node Dissection in Bladder Cancer Patients Undergoing Radical Cystectomy: Survival Results from a Prospective, Randomized Trial
European Urology · 2018 · 10.1016/j.eururo.2018.09.047
Circulating Tumor DNA Reveals Clinically Actionable Somatic Genome of Metastatic Bladder Cancer
Clinical Cancer Research · 2017 · https://doi.org/10.1158/1078-0432.ccr-17-1140
Randomized Phase III Trial of Adjuvant Pazopanib Versus Placebo After Nephrectomy in Patients With Localized or Locally Advanced Renal Cell Carcinoma
Journal of Clinical Oncology · 2017 · https://doi.org/10.1200/jco.2017.73.5324
Comparison of 68Ga-labelled PSMA-11 and 11C-choline in the detection of prostate cancer metastases by PET/CT
European Journal of Nuclear Medicine and Molecular Imaging · 2016 · https://doi.org/10.1007/s00259-016-3490-6
Phase III Study of Cabozantinib in Previously Treated Metastatic Castration-Resistant Prostate Cancer: COMET-1
Journal of Clinical Oncology · 2016 · https://doi.org/10.1200/jco.2015.65.5597
Self-adjuvanted mRNA vaccination in advanced prostate cancer patients: a first-in-man phase I/IIa study
Journal for ImmunoTherapy of Cancer · 2015 · 10.1186/s40425-015-0068-y
Best Practices in Robot-assisted Radical Cystectomy and Urinary Reconstruction: Recommendations of the Pasadena Consensus Panel
European Urology · 2015 · https://doi.org/10.1016/j.eururo.2014.12.009
Prevention and early detection of prostate cancer
The Lancet Oncology · 2014 · https://doi.org/10.1016/s1470-2045(14)70211-6
The Economics of Bladder Cancer: Costs and Considerations of Caring for This Disease
European Urology · 2014 · https://doi.org/10.1016/j.eururo.2014.01.006
Photodynamic Diagnosis of Non–muscle-invasive Bladder Cancer with Hexaminolevulinate Cystoscopy: A Meta-analysis of Detection and Recurrence Based on Raw Data
European Urology · 2013 · https://doi.org/10.1016/j.eururo.2013.03.059
Urinary diversion after radical cystectomy for bladder cancer: options, patient selection, and outcomes
British Journal of Urology · 2013 · 10.1111/bju.12121
Multipeptide immune response to cancer vaccine IMA901 after single-dose cyclophosphamide associates with longer patient survival
Nature Medicine · 2012 · https://doi.org/10.1038/nm.2883
Urothelial Carcinoma of the Bladder and the Upper Tract: Disparate Twins
The Journal of Urology · 2012 · https://doi.org/10.1016/j.juro.2012.05.079
ICUD-EAU International Consultation on Bladder Cancer 2012: Radical Cystectomy and Bladder Preservation for Muscle-Invasive Urothelial Carcinoma of the Bladder
European Urology · 2012 · 10.1016/j.eururo.2012.08.009
Treatment of Muscle-invasive and Metastatic Bladder Cancer: Update of the EAU Guidelines
European Urology · 2011 · https://doi.org/10.1016/j.eururo.2011.03.023
Hexaminolevulinate Guided Fluorescence Cystoscopy Reduces Recurrence in Patients With Nonmuscle Invasive Bladder Cancer
The Journal of Urology · 2010 · 10.1016/j.juro.2010.06.148
The Updated EAU Guidelines on Muscle-Invasive and Metastatic Bladder Cancer
European Urology · 2009 · https://doi.org/10.1016/j.eururo.2009.01.002
Prostate Cancer Gene 3 (PCA3): Development and Internal Validation of a Novel Biopsy Nomogram
European Urology · 2009 · https://doi.org/10.1016/j.eururo.2009.03.029
Economic aspects of bladder cancer: what are the benefits and costs?
World Journal of Urology · 2009 · https://doi.org/10.1007/s00345-009-0395-z
Photodynamic Diagnosis in Non–Muscle-Invasive Bladder Cancer: A Systematic Review and Cumulative Analysis of Prospective Studies
European Urology · 2009 · 10.1016/j.eururo.2009.11.041
Generation of pluripotent stem cells from adult human testis
Nature · 2008 · https://doi.org/10.1038/nature07404
Clinical Utility of the PCA3 Urine Assay in European Men Scheduled for Repeat Biopsy
European Urology · 2008 · https://doi.org/10.1016/j.eururo.2008.06.071
Urinary Diversion
Urology · 2007 · 10.1016/j.urology.2006.05.058
Current projects
No projects listed.